Mumbai, Maharashtra
GST No. 27AGUPM2690J1ZO
Call 08048952877 77% Response Rate
Send Enquiry
Product Brochure
| Dose/Strength | 100 mg |
| Form | Tablet |
| Brand | Bracanat |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 30 Tablets |
| Manufacturer | Natco |
| Composition | Olaparib |
| Treatment | Prostate Cancer |
View Complete details
Product Brochure
| Dose/Strength | 100 mg |
| Form | Tablet |
| Brand | Canrib |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 60 Tablets |
| Manufacturer | Adley |
| Composition | Olaparib |
| Treatment | Prostate Cancer |
View Complete details
Product Brochure
| Dose/Strength | 150 mg |
| Form | Tablet |
| Brand | Olabuzz |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 60 Tablets |
| Composition | Olaparib |
| Shelf Life | 24 Months |
| Manufacturer | Jasgur |
| Treatment | Anticancer Medication |
Olabuzz 150mg Tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors, containing the active ingredient Olaparib. It is used to treat pancreatic, and prostate cancer. This medication can be given alone or in combination with other anticancer medications.
It is not recommended to take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment, if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished.
While receiving treatment, it is not advised to breastfeed your child because it is unknown if Olabuzz 150mg Tablet will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking including prescription, over the counter drugs, vitamins and supplements.
Uses of Olabuzz 150mg TabletTherapeutic Effects of Olabuzz 150mg Tablet
Olabuzz 150mg Tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Olabuzz 150mg Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
Interaction of Olabuzz 150mg Tablet with other drugsInform your healthcare provider about all the medicines you take, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Olabuzz 150mg Tablet and reduce effectiveness by causing undesirable side effects.
View Complete details
Product Brochure
| Dose/Strength | 150 mg |
| Form | Tablet |
| Brand | Olayta |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 60 Tablets |
| Shelf Life | 24 Months |
| Manufacturer | Halsted |
| Composition | Olaparib |
| Treatment | Prostate Cancer |
Olayta 150mg Tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors, containing the active ingredient Olaparib. It is used to treat pancreatic, and prostate cancer. This medication can be given alone or in combination with other anticancer medications.
It is not recommended to take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment, if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because it is unknown if Olayta 150mg Tablet will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking including prescription, over the counter drugs, vitamins and supplements.
Therapeutic Effects of Olayta 150mg Tablet
Olayta 150mg Tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Olparib 150mg Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
View Complete details
Product Brochure
| Dose/Strength | 150 mg |
| Form | Tablet |
| Brand | Canrib |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 60 Tablets |
| Composition | Olaparib |
| Shelf Life | 12 Months |
| Manufacturer | Adley |
| Treatment | Breast Cancer |
It is not recommended to take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment, if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because it is unknown if Canrib 150mg Tablet will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking including prescription, over the counter drugs, vitamins and supplements.
Uses of Canrib 150mg TabletTherapeutic Effects of Canrib 150mg Tablet
Canrib 150mg Tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Canrib 150mg Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
View Complete details
Product Brochure
| Dose/Strength | 150 mg |
| Form | Tablet |
| Brand | Bracanat |
| Packaging Type | Box |
| Packaging Size | 30 Tablets |
| Shelf Life | 36 Months |
| Manufacturer | Natco |
| Composition | Olaparib |
| Treatment | Breast Cancer |
View Complete details
Product Brochure
| Dose/Strength | 150 mg |
| Form | Tablet |
| Brand | Obparp |
| Packaging Type | Box |
| Packaging Size | 7 x 8 Tablets |
| Manucaturer | Cipla |
| Composition | Olaparib |
| Treatment | Breast Cancer |
OBParp 150mg Tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors, containing the active ingredient Olaparib. It is used to treat pancreatic, and prostate cancer. This medication can be given alone or in combination with other anticancer medications.
It is not recommended to take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment, if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because it is unknown if OBParp 150mg Tablet will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking including prescription, over the counter drugs, vitamins and supplements.
Uses of Obparp 150mg TabletTherapeutic Effects of Obparp 150mg Tablet
OBParp 100mg/150mg Tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Olparib 150mg Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
View Complete details
Product Brochure
| Dose/Strength | 150 mg |
| Form | Tablet |
| Brand | Bdparp |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 56 Tablets |
| Manufacturer | BDR |
| Composition | Olaparib |
| Treatment | Treat Ovarian |
Bdparp tablet is an antiviral drug belonging to the polyadenosine diphosphate-ribose polymerase (PARP) inhibitor category. It contains the active ingredient Olaparib. It is used to treat pancreatic and prostate cancer. Cancer is a disease in which cells multiply uncontrollably and abnormally. This medication can be given alone or in combination with other anticancer medications.
Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
This drug is not recommended during pregnancy as it might harm the unborn baby and lead to miscarriage. Hence, it is advisable to do a pregnancy test before starting this treatment for women of childbearing age. Ideally, it is better to continue birth control methods for a minimum of 6 months after completion of the treatment. Avoid breastfeeding your baby while you are on the treatment, as it is unknown whether the Bdparp tablet passes into the breast milk.
Uses of Bdparp 150mg Tablet 28'sTherapeutic Effects of Bdparp 150mg Tablet 28's
Bdparp tablet works by inhibiting PARP enzymes, blocks the repair of single-stranded DNA, and ultimately hinders the growth and development of cancer cells.
View Complete details
Product Brochure
| Dose/Strength | 100 mg |
| Form | Tablet |
| Brand | Ibyra |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 60 Tablets |
| Composition | Olaparib |
| Manufacturer | Zydus |
| Treatment | Prostate Cancer |
Ibyra 100mg Tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors, containing the active ingredient Olaparib. It is used to treat pancreatic, and prostate cancer. This medication can be given alone or in combination with other anticancer medications.
It is not recommended to take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment, if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because it is unknown if Ibyra 100mg Tablet will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking including prescription, over the counter drugs, vitamins and supplements.
Uses of Ibyra 100mg TabletTherapeutic Effects of Ibyra 100mg Tablet
Ibyra 100mg Tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Ibyra 100mg Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
View Complete details
Product Brochure
| Dose/Strength | 150 mg |
| Form | Tablet |
| Brand | Ibyra |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 60 Tablets |
| Manufacturer | Zydus |
| Composition | Olaparib |
| Treatment | Prostate Cancer |
Ibyra 150mg Tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors, containing the active ingredient Olaparib. It is used to treat pancreatic, and prostate cancer. This medication can be given alone or in combination with other anticancer medications.
It is not recommended to take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment, if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because it is unknown if Ibyra 150mg Tablet will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking including prescription, over the counter drugs, vitamins and supplements.
Uses of Ibyra 150mg TabletTherapeutic Effects of Ibyra 150mg Tablet
Ibyra 150mg Tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Ibyra 150mg Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
View Complete details
Product Brochure
| Dose/Strength | 100 mg |
| Form | Tablet |
| Brand | Ribaxa Plus |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 60 Tablets |
| Manufacturer | Dr.Reddy's |
| Composition | Olaparib |
| Treatment | Prostate Cancer |
Ribaxa Plus 100mg tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors, containing the active ingredient Olaparib. It is used to treat pancreatic, and prostate cancer. This medication can be given alone or in combination with other anticancer medications.
It is not recommended to take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment, if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because it is unknown if Ribaxa Plus 100mg tablet will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking including prescription, over the counter drugs, vitamins and supplements.
Uses of Ribaxa Plus 100mg TabletTherapeutic Effects of Ribaxa Plus 100mg Tablet
Ribaxa Plus 100mg tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Ribaxa Plus 100mg tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
View Complete details
Product Brochure
| Dose/Strength | 100 mg |
| Form | Tablet |
| Brand | Obrenza |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 60 Tablets |
| Composition | Olaparib |
| Manufacturer | Sun Pharma |
| Treatment | Prostate Cancer |
View Complete details
Product Brochure
| Dose/Strength | 150 mg |
| Form | Tablet |
| Brand | Brcaone |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 60 Tablets |
| Composition | Olaparib |
| Manufacturer | Emcure |
| Treatment | Prostate Cancer |
View Complete details
Product Brochure
| Dose/Strength | 100 mg |
| Form | Tablet |
| Brand | Lupiparb |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 60 Tablets |
| Manufacturer | Lupin |
| Composition | Olaparib |
| Treatment | Prostate Cancer |
View Complete details
Product Brochure
| Dose/Strength | 150 mg |
| Form | Tablet |
| Brand | Brcaone |
| Packaging Type | Box |
| Packaging Size | 60 Tablets |
| Manufacturer | Emcure |
| Composition | Olaparib |
| Treatment | Breast Cancer |
Brcaone 150mg Tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors, containing the active ingredient Olaparib. It is used to treat pancreatic, and prostate cancer. This medication can be given alone or in combination with other anticancer medications.
It is not recommended to take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment, if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because it is unknown if Brcaone 150mg Tablet will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking including prescription, over the counter drugs, vitamins and supplements.
Uses of Brcaone 150mg TabletTherapeutic Effects of Brcaone 150mg Tablet
Brcaone 150mg Tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Brcaone 150mg Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
View Complete details
Product Brochure
| Dose/Strength | 150 mg |
| Form | Tablet |
| Brand | Lupiparp |
| Packaging Type | Box |
| Packaging Size | 60 Tablets |
| Manufacturer | Lupin |
| Composition | Olaparib |
| Treatment | Breast Cancer |
Lupiparp 150mg Tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors, containing the active ingredient Olaparib. It is used to treat pancreatic, and prostate cancer. This medication can be given alone or in combination with other anticancer medications.
It is not recommended to take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment, if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because it is unknown if Lupiparp 150mg Tablet will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking including prescription, over-the-counter drugs, vitamins and supplements.
Uses of Lupiparp 150mg TabletTherapeutic Effects of Lupiparp 150mg Tablet
Lupiparp 150mg Tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Lupiparp 150mg Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
View Complete details
Product Brochure
| Dose/Strength | 150 mg |
| Form | Tablet |
| Brand | Bracaloc |
| Packaging Type | Box |
| Packaging Size | 30 Tablets |
| Manufacturer | Samarth |
| Composition | Olaparib |
| Treatment | Treat Breast Cancer |
Bracaloc 150mg Tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors, containing the active ingredient Olaparib. It is used to treat pancreatic, and prostate cancer. This medication can be given alone or in combination with other anticancer medications.
It is not recommended to take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment, if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because it is unknown if Bracaloc 150mg Tablet will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking including prescription, over the counter drugs, vitamins and supplements.
Uses of Bracaloc 150mg TabletTherapeutic Effects of Bracaloc 150mg Tablet
Bracaloc 150mg Tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Bracaloc 150mg Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
View Complete details
Product Brochure
| Dose/Strength | 150 mg |
| Form | Tablet |
| Brand | Obrenza |
| Packaging Type | Box |
| Packaging Size | 60 Tablets |
| Manufacturer | Sun Pharma |
| Composition | Olaparib |
| Treatment | Treat Breast Cancer |
Obrenza 100mg Tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors, containing the active ingredient Olaparib. It is used to treat pancreatic, and prostate cancer. This medication can be given alone or in combination with other anticancer medications.
It is not recommended to take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment, if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because it is unknown if Obrenza 100mg Tablet will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking including prescription, over the counter drugs, vitamins and supplements.
Uses of Obrenza 150mg TabletTherapeutic Effects of Obrenza 150mg Tablet
Obrenza 100mg Tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Obrenza 100mg Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
View Complete details
Product Brochure
| Dose/Strength | 150 mg |
| Form | Tablet |
| Brand | Olpaza |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 30 Tablets |
| Manufacturer | Intas |
| Composition | Olaparib |
| Treatment | Breast Cancer |
Olpaza 150mg Tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors, containing the active ingredient Olaparib. It is used to treat pancreatic, and prostate cancer. This medication can be given alone or in combination with other anticancer medications.
It is not recommended to take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment, if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because it is unknown if Olpaza 150mg Tablet will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking including prescription, over the counter drugs, vitamins and supplements.
Uses of Olpaza 150mg TabletTherapeutic Effects of Olpaza 150mg Tablet
Olpaza 150mg Tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Olparib 150mg Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
View Complete details
Product Brochure
| Dose/Strength | 150 mg |
| Form | Tablet |
| Brand | Ribaxa Plus |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 60 Tablets |
| Composition | Olaparib |
| Manufacturer | Dr.Reddy's |
| Treatment | Treat Ovarian |
Ribaxa Plus 150mg Tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors, containing the active ingredient Olaparib. It is used to treat pancreatic, and prostate cancer. This medication can be given alone or in combination with other anticancer medications.
It is not recommended to take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment, if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because it is unknown if Ribaxa Plus 100mg tablet will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking including prescription, over the counter drugs, vitamins and supplements.
Uses of Ribaxa Plus 150mg TabletView Complete details
Product Brochure
| Dose/Strength | 150 mg |
| Form | Tablet |
| Brand | Femmeola |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 120 Tablets |
| Manufacturer | Medicamen |
| Composition | Olaparib |
| Treatment | Treat Ovarian |
Femmeola Tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors. It contains the active ingredient Olaparib. It is used to treat pancreatic and prostate cancer. This medication can be given alone or in combination with other anticancer drugs.
It is not recommended to take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because it is unknown if Femmeola Tablet will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking, including prescription, over-the-counter drugs, vitamins and supplements.
Uses of Femmeola 150mg Tablet 60'sTherapeutic Effects of Femmeola 150mg Tablet 60's
Ribaxa Plus 100mg tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Femmeola Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
View Complete details
Product Brochure
| Dose/Strength | 150 mg |
| Form | Tablet |
| Brand | Lynza |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 30 Tablets |
| Manufacturer | Oncology |
| Composition | Olaparib |
| Treatment | Treat Ovarian |
Lynza 150mg Tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors, containing the active ingredient Olaparib. It is used to treat pancreatic, and prostate cancer. This medication can be given alone or in combination with other anticancer medications.
It is not recommended to take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment, if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because it is unknown if Lynza 150mg Tablet 30'S will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking including prescription, over the counter drugs, vitamins and supplements.
Uses of Lynza 150mg TabletTherapeutic Effects of Lynza 150mg Tablet
Lynza 150mg Tablet 30'S works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Olparib 150mg Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
View Complete details
Product Brochure
| Dose/Strength | 150 mg |
| Form | Tablet |
| Brand | Olabir |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 120 Tablets |
| Composition | Olaprib |
| Shelf Life | 24 Months |
| Manufacturer | Aprazer |
| Treatment | Treat Ovarian |
Olabir Tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors. It contains the active ingredient Olaparib. It is used to treat pancreatic and prostate cancer. This medication can be given alone or in combination with other anticancer medications.
It is not recommended to take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because it is unknown if Olabir Tablet will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking, including prescription, over-the-counter drugs, vitamins and supplements.
Uses of Olabir 150mg Tablet 30'sTherapeutic Effects of Olabir 150mg Tablet 30's
Olabir Tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Olabir Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
View Complete details
Product Brochure
| Dose/Strength | 150 mg |
| Form | Tablet |
| Brand | Pariblieva |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 30 Tablets |
| Composition | Olaparib |
| Manufacturer | Allieva |
| Treatment | Treat Ovarian |
Pariblieva 150mg Capsule belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors, containing the active ingredient Olaparib. It is used to treat ovarian, breast, pancreatic, and prostate cancer. This medication can be given alone or in combination with other anticancer medications.
It is not recommended to take Pariblieva 150mg Capsule if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment, if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because it is unknown if Pariblieva 150mg Capsule will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking including prescription, over the counter drugs, vitamins and supplements.
Pariblieva 150mg Capsule is used to treat,
Therapeutic Effects of Pariblieva 150mg Capsule
Pariblieva 150mg Capsule works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Pariblieva 150mg Capsule prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
View Complete details
Minimum Order Quantity: 1 Box
Product Brochure
| Dose/Strength | 100 mg |
| Form | Tablet |
| Usage/Application | Hospital |
| Brand | Lynza 100mg Tablet |
| Drug Name | Olaparib 100mg Tablets |
| Packaging Type | Tablets |
| Packaging Size | 1x30's |
| Country of Origin | Made in India |
View Complete details
Product Brochure
| Dose/Strength | 100 mg |
| Form | Tablet |
| Brand | Bdparp |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 56 Tablets |
| Manufacturer | BDR |
| Composition | Olaparib |
| Treatment | Treat Ovarian |
Bdparp tablet is an antiviral drug belonging to the polyadenosine diphosphate-ribose polymerase (PARP) inhibitor category. It contains the active ingredient Olaparib. It is used to treat pancreatic and prostate cancer. Cancer is a disease in which cells multiply uncontrollably and abnormally. This medication can be given alone or in combination with other anticancer medications.
Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
This drug is not recommended during pregnancy as it might harm the unborn baby and lead to miscarriage. Hence, it is advisable to do a pregnancy test before starting this treatment for women of childbearing age. Ideally, it is better to continue birth control methods for a minimum of 6 months after completion of the treatment. Avoid breastfeeding your baby while you are on the treatment, as it is unknown whether the Bdparp tablet passes into the breast milk.
Uses of Bdparp 100mg Tablet 56'sTherapeutic Effects of Bdparp 100mg Tablet 56's
Bdparp tablet works by inhibiting PARP enzymes, blocks the repair of single-stranded DNA, and ultimately hinders the growth and development of cancer cells.
Interaction of Bdparp 100mg Tablet 56's with other drugsInform your healthcare provider about all the medicines you take, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Bdparp tablets and reduce effectiveness by causing undesirable side effects.
More Information about Bdparp 100mg Tablet 56'sView Complete details
Product Brochure
| Dose/Strength | 150 mg |
| Form | Tablet |
| Brand | Femmeola |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 30 Tablets |
| Manufacturer | Medicamen |
| Composition | Olaparib |
| Treatment | Breast Cancer |
Femmola 150mg Tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors. It contains the active ingredient Olaparib. It is used to treat ovarian, breast, pancreatic, and prostate cancer. This medication can be given alone or in combination with other anticancer medications.
It is not recommended to take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because it is unknown if the Parbraze 150mg Tablet will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking, including prescription, over-the-counter drugs, vitamins and supplements.
Uses of Parbraze 150mg TabletParbraze 150mg Tablet is used to treat,
Therapeutic Effects of Parbraze 150mg Tablet
Parbraze 150mg Tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Parbraze 150mg Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
View Complete details
Product Brochure
| Dose/Strength | 150 mg |
| Form | Tablet |
| Brand | Lynparza |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 7 X 8 Tablets |
| Composition | Olaparib |
| Manufacturer | Astrazeneca |
| Treatment | Breast Cancer |
View Complete details